Want to join the conversation?
$BIIB said on early stage research, it entered into a broad collaboration and alliance with the University of Pennsylvania and two world-renowned gene therapy experts, Dr. James Wilson and Dr. Jean Bennett. During the ECTRIMS conference in Sept. 2016, $BIIB expects to present more detailed efficacy, biomarker & safety data from opicinumab.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)